Autonomix Medical investor exercises warrants for USD 4.9 million in stock purchase
AMIX•Warrant inducement and expected proceeds
- Autonomix Medical entered a warrant inducement for immediate cash exercise of 857,462 July 2026 Warrants at USD 5.75.
- Gross proceeds expected at about USD 4.9 million, before fees and offering expenses; closing targeted around Aug. 26, 2026.
- Incentive includes unregistered Series E-1, Series E-2 warrants for 535,913 shares each; exercise price USD 6.25; five-year term.
- Shares from the July 2026 Warrant exercise are registered on an effective Form S-3; registration planned for resale shares from New Warrants.
